Japan Facial Rejuvenation Market

ID: MRFR/HC/49496-HCR
200 Pages
Satyendra Maurya
Last Updated: February 06, 2026
Japan Facial Rejuvenation Market Research Report: Size, Share, Trend Analysis By Treatment Type (Surgical Procedures, Non-Surgical Procedures, Injectables, Laser Treatments), By Procedure Category (Facelift, Botox Injections, Dermal Fillers, Chemical Peels), By Skin Type (Aging Skin, Dry Skin, Oily Skin, Combination Skin) and By Target Group (Men, Women, Aging Population) - Growth Outlook & Industry Forecast 2025 To 2035
Japan Facial Rejuvenation Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)5.0%
2024 Market Size$ 780.56 Million
2025 Market Size$ 819.59 Million
2035 Market Size$ 1,335 Million
Key Players
Allergan
Revance Therapeutics
Medytox - remove duplicate entry.
Galderma
Ipsen
Hugel
Trends
  • Rise of Non-Invasive Procedures
  • Technological Advancements
  • Cultural Acceptance of Cosmetic Procedures
Opportunities
  • Rise of Medical Tourism
  • Innovations in Product Offerings
  • Aging Population and Longevity Trends
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Construction, BY Type (USD Million)
      1. 4.1.1 Surgical Procedures
      2. 4.1.2 Non-Surgical Procedures
      3. 4.1.3 Injectables
      4. 4.1.4 Laser Treatments
    2. 4.2 Construction, BY Procedure Category (USD Million)
      1. 4.2.1 Facelift
      2. 4.2.2 Botox Injections
      3. 4.2.3 Dermal Fillers
      4. 4.2.4 Chemical Peels
    3. 4.3 Construction, BY Skin Type (USD Million)
      1. 4.3.1 Aging Skin
      2. 4.3.2 Dry Skin
      3. 4.3.3 Oily Skin
      4. 4.3.4 Combination Skin
    4. 4.4 Construction, BY Target Group (USD Million)
      1. 4.4.1 Men
      2. 4.4.2 Women
      3. 4.4.3 Aging Population
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Construction
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Construction
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Allergan (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Revance Therapeutics (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Medytox (KR) - remove duplicate entry.
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Galderma (CH)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Ipsen (FR)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Hugel (KR)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Medytox (KR)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Sientra (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Hugel (KR)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 JAPAN MARKET ANALYSIS BY TYPE
    3. 6.3 JAPAN MARKET ANALYSIS BY PROCEDURE CATEGORY
    4. 6.4 JAPAN MARKET ANALYSIS BY SKIN TYPE
    5. 6.5 JAPAN MARKET ANALYSIS BY TARGET GROUP
    6. 6.6 KEY BUYING CRITERIA OF CONSTRUCTION
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF CONSTRUCTION
    9. 6.9 DRIVERS IMPACT ANALYSIS: CONSTRUCTION
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: CONSTRUCTION
    11. 6.11 SUPPLY / VALUE CHAIN: CONSTRUCTION
    12. 6.12 CONSTRUCTION, BY TYPE, 2024 (% SHARE)
    13. 6.13 CONSTRUCTION, BY TYPE, 2024 TO 2035 (USD Million)
    14. 6.14 CONSTRUCTION, BY PROCEDURE CATEGORY, 2024 (% SHARE)
    15. 6.15 CONSTRUCTION, BY PROCEDURE CATEGORY, 2024 TO 2035 (USD Million)
    16. 6.16 CONSTRUCTION, BY SKIN TYPE, 2024 (% SHARE)
    17. 6.17 CONSTRUCTION, BY SKIN TYPE, 2024 TO 2035 (USD Million)
    18. 6.18 CONSTRUCTION, BY TARGET GROUP, 2024 (% SHARE)
    19. 6.19 CONSTRUCTION, BY TARGET GROUP, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 Japan MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY PROCEDURE CATEGORY, 2025-2035 (USD Million)
      3. 7.2.3 BY SKIN TYPE, 2025-2035 (USD Million)
      4. 7.2.4 BY TARGET GROUP, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

Japan Facial Rejuvenation Market Segmentation

Japan Facial Rejuvenation Market By Type (USD Million, 2025-2035)

  • Surgical Procedures
  • Non-Surgical Procedures
  • Injectables
  • Laser Treatments

Japan Facial Rejuvenation Market By Procedure Category (USD Million, 2025-2035)

  • Facelift
  • Botox Injections
  • Dermal Fillers
  • Chemical Peels

Japan Facial Rejuvenation Market By Skin Type (USD Million, 2025-2035)

  • Aging Skin
  • Dry Skin
  • Oily Skin
  • Combination Skin

Japan Facial Rejuvenation Market By Target Group (USD Million, 2025-2035)

  • Men
  • Women
  • Aging Population

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.